Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · SANTA FE, NM · NPI 1669460580
Verified facts
CMS Open Payments records show Sue Katz, MD received $17.88 in general payments during 2025 across 1 reported records.
Indivior Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Indivior Inc. | Unresolved — no canonical attribution shown | $17.88 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.88 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SUBLOCADE Normalized: sublocade |
Drug | Indivior Inc. | $17.88 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 319 | 90 |
| Levothyroxine Sodium | Levothyroxine Sodium | 255 | 63 |
| Gabapentin | Gabapentin | 196 | 40 |
| Mirtazapine | Mirtazapine | 180 | 44 |
| Omeprazole | Omeprazole | 178 | 48 |
| Lisinopril | Lisinopril | 162 | 49 |
| Losartan Potassium | Losartan Potassium | 134 | 47 |
| Tamsulosin Hcl | Tamsulosin Hcl | 128 | 37 |
| Trazodone Hcl | Trazodone Hcl | 125 | 24 |
| Amlodipine Besylate | Amlodipine Besylate | 117 | 30 |
| Ibuprofen | Ibuprofen | 101 | 24 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 99 | 24 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 95 | 34 |
| Oxycodone Hcl | Oxycodone Hcl | 93 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 89 | 24 |
| Metformin Hcl | Metformin Hcl | 89 | 33 |
| Zolpidem Tartrate | Zolpidem Tartrate | 86 | 20 |
| Lorazepam | Lorazepam | 85 | 17 |
| Metoprolol Succinate | Metoprolol Succinate | 85 | 26 |
| Tramadol Hcl | Tramadol Hcl | 80 | 20 |
| Fluticasone Propionate | Fluticasone Propionate | 74 | 30 |
| Quetiapine Fumarate | Quetiapine Fumarate | 74 | 18 |
| Eliquis | Apixaban | 71 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 68 | suppressed |
| Furosemide | Furosemide | 67 | 19 |
| Clonazepam | Clonazepam | 66 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 65 | 17 |
| Simvastatin | Simvastatin | 60 | 15 |
| Metoprolol Tartrate | Metoprolol Tartrate | 59 | 17 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 57 | 15 |
| Alprazolam | Alprazolam | 56 | suppressed |
| Pantoprazole Sodium | Pantoprazole Sodium | 55 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 53 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 53 | 14 |
| Alendronate Sodium | Alendronate Sodium | 51 | 21 |
| Sertraline Hcl | Sertraline Hcl | 51 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 48 | 12 |
| Finasteride | Finasteride | 46 | 16 |
| Lovastatin | Lovastatin | 46 | suppressed |
| Pregabalin | Pregabalin | 42 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 42 | 16 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 41 | 41 |
| Famotidine | Famotidine | 41 | 12 |
| Ozempic | Semaglutide | 40 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 39 | 16 |
| Januvia | Sitagliptin Phosphate | 39 | suppressed |
| Jardiance | Empagliflozin | 38 | suppressed |
| Glipizide | Glipizide | 34 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 33 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 32 | suppressed |
| Acyclovir | Acyclovir | 31 | 15 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 31 | suppressed |
| Allopurinol | Allopurinol | 30 | suppressed |
| Memantine Hcl | Memantine Hcl | 30 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 30 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 29 | 13 |
| Potassium Chloride | Potassium Chloride | 29 | suppressed |
| Trulicity | Dulaglutide | 29 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 27 | suppressed |
| Levetiracetam | Levetiracetam | 27 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 27 | 25 |
| Meloxicam | Meloxicam | 26 | suppressed |
| Spironolactone | Spironolactone | 26 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 25 | suppressed |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Cephalexin | Cephalexin | 22 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 22 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 21 | suppressed |
| Estradiol | Estradiol | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 20 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 19 | suppressed |
| Carisoprodol | Carisoprodol | 19 | suppressed |
| Carvedilol | Carvedilol | 19 | suppressed |
| Colchicine | Colchicine | 19 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 19 | suppressed |
| Fluconazole | Fluconazole | 19 | 12 |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 19 | suppressed |
| Atenolol | Atenolol | 18 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 18 | suppressed |
| Irbesartan | Irbesartan | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Topiramate | Topiramate | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Hydrocortisone | Hydrocortisone | 17 | suppressed |
| Naproxen | Naproxen | 17 | suppressed |
| Prednisone | Prednisone | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Anastrozole | Anastrozole | 14 | suppressed |
| Armour Thyroid | Thyroid,pork | 14 | suppressed |
| Bupropion Xl | Bupropion Hcl | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Risperidone Odt | Risperidone | 14 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 14 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Celecoxib | Celecoxib | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Hydroxyurea | Hydroxyurea | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Repatha Sureclick | Evolocumab | 12 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.88 · 1 records | Indivior Inc. | SUBLOCADE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error